LEADER 05301nam 2201777z- 450 001 9910595075503321 005 20231214133315.0 035 $a(CKB)5680000000080771 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/92078 035 $a(EXLCZ)995680000000080771 100 $a20202209d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aA Personalized Medicine Approach to the Diagnosis and Management of Autism Spectrum Disorder 210 $aBasel$cMDPI Books$d2022 215 $a1 electronic resource (416 p.) 311 $a3-0365-3221-8 311 $a3-0365-3220-X 330 $aThis collection of articles provides an overview of the current and future methods for applying a personalized medicine approach to the diagnosis, management, and treatment of autism spectrum disorder. 606 $aMedicine$2bicssc 606 $aNeurosciences$2bicssc 610 $afecal metabolites 610 $aASD 610 $amicrobiome 610 $agastrointestinal symptoms 610 $aFisher Discriminant Analysis 610 $adigital biomarkers 610 $awearables 610 $atime series analysis 610 $aautism 610 $asocial dyads 610 $asocio-motor parameters 610 $anetwork connectivity 610 $anon-linear complex dynamics 610 $astochastic analysis 610 $aautism spectrum disorders 610 $acopy number variants 610 $afemales 610 $aArray-Comparative Genomic Hybridization (Array-CGH) 610 $aautism spectrum disorder 610 $aEhlers-Danlos syndrome 610 $ahypermobility spectrum disorders 610 $aautonomic disorder 610 $amast cell activation syndrome 610 $agenetic testing 610 $achromosomal microarray analysis 610 $awhole exome sequencing 610 $awhole genome sequencing 610 $aclinical utility 610 $apolygenic risk scores 610 $aTemple Grandin 610 $abiomarker 610 $aomics 610 $aprecision medicine 610 $aproteomics 610 $atranscriptomics 610 $aepigenetics 610 $ametabolomics 610 $apatient stratification 610 $amitochondria 610 $aoxidative stress 610 $aprenatal environment 610 $aimmune dysfunction 610 $aimmunoglobulin G 610 $aintravenous immunoglobulin 610 $aenergy metabolism 610 $afatty acid oxidation 610 $aacyl-carnitines 610 $aresveratrol 610 $aintegrative 610 $amodel 610 $aconcomitant 610 $acondition 610 $adisorder 610 $aautism spectrum disorder (ASD) 610 $agenomics 610 $apersonalized treatment strategy 610 $asingle nucleotide polymorphisms 610 $aclinical decision support tool 610 $aADHD 610 $aPANDAS 610 $aOCD 610 $aanxiety 610 $afolate receptor alpha 610 $afolates 610 $apregnancy 610 $abrain development 610 $afetal development 610 $acobalamin 610 $aglutathione 610 $amethylation 610 $amethylcobalamin 610 $aredox metabolism 610 $alocked-in network syndrome 610 $aresting-state functional magnetic resonance imaging 610 $atemporal lobe epilepsy 610 $aamygdala 610 $abrain 610 $aCOVID-19 610 $achildren 610 $acytokines 610 $aflavonoids 610 $ainflammation 610 $aluteolin 610 $amast cells 610 $amicroglia 610 $aSARS-CoV-2 610 $astress 610 $anutraceuticals 610 $asurvey 610 $avitamins 610 $aminerals 610 $aB12 610 $afolinic acid 610 $aquality of life 610 $aparents 610 $aintervention 610 $asystematic review 610 $amedical claims 610 $alogistic regression analysis 610 $aretrospective analysis 610 $aassociated risk 610 $amonoamine neurotransmitters 610 $aneurotransmitter deficiency 610 $acerebral folate deficiency 610 $afolate receptor alpha autoantibodies 610 $aleucovorin 610 $a?-amylase 610 $acortisol 610 $aheart rate variability 610 $aneuromodulation 610 $asleep anxiety 610 $atransdermal electrical neuromodulation 610 $aneurostimulation 615 7$aMedicine 615 7$aNeurosciences 700 $aFrye$b Richard E$4edt$0161897 702 $aBoles$b Richard$4edt 702 $aRose$b Shannon$4edt 702 $aRossignol$b Daniel$4edt 702 $aFrye$b Richard E$4oth 702 $aBoles$b Richard$4oth 702 $aRose$b Shannon$4oth 702 $aRossignol$b Daniel$4oth 906 $aBOOK 912 $a9910595075503321 996 $aA Personalized Medicine Approach to the Diagnosis and Management of Autism Spectrum Disorder$93040835 997 $aUNINA